Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
NCT00900250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1271
Last updated 2019-04-10
Summary
This laboratory study is collecting and storing samples of tissue and blood from young patients with Hodgkin's lymphoma. Collecting and storing samples of tumor tissue and blood from patients with cancer to study in the laboratory may help the study of cancer in the future.
Conditions
- Ann Arbor Stage I Childhood Hodgkin Lymphoma
- Ann Arbor Stage II Childhood Hodgkin Lymphoma
- Ann Arbor Stage III Childhood Hodgkin Lymphoma
- Ann Arbor Stage IV Childhood Hodgkin Lymphoma
- Refractory Childhood Hodgkin Lymphoma
Interventions
- OTHER
-
Cytology Specimen Collection Procedure
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Meghan A Higman · Children's Oncology Group
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-23
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- United States
- Australia
- Canada
- Switzerland
Study Locations
More Related Trials
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).
NCT00301314 ·Status: COMPLETED
-
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
NCT01318317 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Assess AFM13 in Patients With Hodgkin Lymphoma
NCT01221571 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
NCT00322985 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT02856646 ·Status: COMPLETED
-
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
NCT02098512 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)
NCT00510133 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
NCT00002221 ·Status: COMPLETED ·Phase: PHASE2
-
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
NCT00720135 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
NCT05138458 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Gonadal Toxicity in Women With Hodgkin Lymphoma
NCT01008735 ·Status: UNKNOWN
-
Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 ·Status: RECRUITING ·Phase: NA
-
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT01745354 ·Status: TERMINATED ·Phase: PHASE1
-
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
NCT00186355 ·Status: COMPLETED ·Phase: NA
-
A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients
NCT04139252 ·Status: UNKNOWN
-
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
NCT04982471 ·Status: TERMINATED
-
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
NCT00398177 ·Status: RECRUITING
-
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
NCT00186394 ·Status: COMPLETED ·Phase: PHASE2
-
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
NCT00685997 ·Status: COMPLETED
-
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
NCT04298619 ·Status: COMPLETED
-
Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study
NCT02691351 ·Status: COMPLETED
-
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
NCT01007292 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
NCT00924131 ·Status: COMPLETED